BIBLIOGRAFIA - L’Attività Assistita con Animali nella Sindrome di Rett: Terapia di supporto al Comportamento e alle abilità Grosso-Motorie

  1. Clinical manifestations and stages of rett syndrome. Hagberg, Bengt. Goteborg : s.n., 2002, MRDD research reviews, p. 5.
  2. Clinical and genetic Rett syndrome variants are defined by stable elecrtrophysiological profiles. Conor, Keogh, et al. ottobre 2018, BMC Pediatrics, p. 15.
  3. On a unusual brain atrophy syndrome in hyperamonemia in childhood. Rett, Andreas.
  4. Rett syndrome is caused by mutations in X-linked MECP2, which encodes protein 2 that binds methyl-CpG. Amir R., Van den Veyver I. , Wan M., Tran C. , Francke U. Houston,Texas : s.n., 1999.
  5. Rett Syndrome Diagnostic Criteria Working Group . Hagberg B., Hanefeld F., Percy A., Skjeldal O. 2002.
  6. Hagberg. 1985.
  7. Olsson, Rett and al, Percy et. 1985; 1987; 1988 ; 1990 .
  8. Rett syndrome: a neurological disorder with metabolic components. Kyle S.M., Vashi N., Justice M.J. 2018.
  9. Preserved speech variant is allelic of classic Rett syndrome. De Bona C., Zappella M., Hayek G., Meloni I., Vitelli F., Bruttini M., Cusano R., Loffredo P., Longo I., Ranieri A. 2000.
  10. CDKL5/ STK9 is mutated in Rett syndrome variant with infantile spasms. Scala E., Ariani F., Mari F., Caselli R., Pescucci C., Longo I., Meloni I., Giachino D., Bruttini M., Hayek G., Zappella M., Ranieri A.
  11. Distruption of Netrin G1 by a balanced chromosome traslocation in a girl with Rett syndrome . Borg I., Freude K., Kubart S., Hoffmann K. 2005.
  12. NTNG1 mutations are a rare cause of Rett syndrome . Archer H.L, Evans J.C, Millar D.S, Thompson P.W. 2006.
  13. FOXG1 is responsible for the congenital variant of Rett syndrome. Ariani F., Hayek G., Rondinella D., Artuso R., Mencarelli M.A., Spanhol- Rosseto A., Pollazzon M., Buoni S., Spiga O., Ricciardi S., Meloni I., Longo I., Mari F., Broccoli V., Zappella M., Ranieri A. 2008.
  14. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Zweier M., Gregor A., Zweier C., Engels. 2010.
  15. De novo SHANK3 mutation causes Rett syndrome- like phenotype in a female patient. Hara M., Ohba C., Yamashita Y., Saitsu H. 2015. 
  16. Deletion of protein tyrosine phosphatase, non-receptor type 4 (PTPN4) in twins with a Rett-syndrome-like ohenotype. Williamson S.L, Ellaway C.J., Peters G.B., Pelka G.J. 2015.
  17. A de-novo STXBP1 gene mutation in a patient showing the Rett syndrome phenotype. Romaniello R., Saettini F., Panzeri E., Ariigoni F. 2015.
  18. WDR45 mutations in Rett syndrome and development delay: case report and an appraisal of the literature. Hoffjan S., Ibisler A., Tschentscher A., Dekomien G. 2016.
  19. An update on clinically applicable diagnostic criteria in Rett syndrome: comments to Rett
    syndrome clinical criteria consensus panel satellite to european pediatric neurology society meeting baden. Hagberg B., Hanefeld F., Percy A., Skjeldal O.,. 2002.
  20. Rett syndrome: revised diagnostic criteria and nomenclature . Neul J.L, Kaufmann E., Glaze D.G, Christodoulou J. 2010.
  21. association, American psychiatric. 1995, Vols. DSM-IV.
  22. association, American psychiatric. s.l. : 2013, Vols. DSM-V.
  23. Rett syndrome: Swedish Approach to analysis of prevalence and cause. Hagberg, B. 1985.
  24. The prevalence of Rett syndrome in Fukui prefecture. K.Terai, T. Munesue, M.Hiratani, J. Zheng-Yan, I.Jibiki,N. Yamaguchi. 1994.
  25. The american history of Rett syndrome. A.Percy. 2014.
  26. A., Briggs. Primary care of a child with Rett syndrome. 2014.
  27. Hollody, Borvenged, Kosztolanyi. Race analysis of girls of the Hungarian Rett syndrome. 1997.
  28. Akesson, Hagberg,wahlstrom. Rett syndrome: presumed carriers of the genetic defect. Sexual relationship between their brothers. 1997.
  29. Importance of Rett syndrome in child neurology . Pini G., Milano M. , Zappella M. Vancouver : s.n., 1996.
  30. Sindrome di rett: un ampio quadro clinico ed autonomo. Zappella, M., et al. 2018, Orphanet journal of rare deseases.
  31. The history of Rett Syndrome: from clinical to neurobiology. M. Chahrour, H.Y. Zoghbi. Houston : s.n., 2007.
  32. MECP2 is a trascriptional repressor with abundant binding sites in genomic chromatin. Nan X., Campoy F.J., Bird A.,. 1997.
  33. De novo mutations in SCN1A are associated with classic Rett syndrome : a case report.
    M.W.Henriksen, K.Ravn, B.Paus, S. von Tetzchner, O.H.Skjeldal. 2018. 
  34. MECP2 de novo mutation in a girl with Rett syndrome. Alexandrou , A., et al. 4 giugno
    2018, Wiley clinical case reports.
  35. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements,epilepsy and/or cerebral malformation. Le Meur N, Holder-Espinasse M, Jaillard S, Goldenberg A, Joriot S, Amati-Bonneau P, Guichet A, Barth M, Charollais A, Journel H, Auvin S, Boucher C, Kerckaert JP, David V, Manouvrier-Hanu S, Saugier-Veber P, Frébourg T, Dubourg C, Andrieux J, Bonneau D. 2010, J Med Genet.
  36. Heterogeneity of residual function of MeCP2 missense mutations bringing in the methyl CpG binding domain. Kudo S., Nomura Y., Segawa M., Fujita N., Nakao M., Scjanen C., Tamura M. 2003.
  37. Interaction between chromatin proteins MECP2 and ATRX is distrupted by mutations that cause inherited mental retardation. Nan X., Hou J., Maclean A., Nasir J., Lafuente M.J, Shu X., Kriaucionis S., Bird A. 2006.
  38. D.D., Armstrong. Neuropathology of Rett syndrome. Journal of Child Neurology. 2005.
  39. Jellinger K., Armstrong D., Zoghbi H.Y, Percy A.K. Neuropathollogy of Rett syndrome.
    1988.
  40. Reiss A.L, Farugue F., Naidu S., Abrams M., Beaty T., Bryan R.N, Moser H. Nuroanatomy of Rett syndrome: a volumetric imaging study. 1993.
  41. Fichou Y., Nectoux J., Bahi-Buisson N., Chelly J., Bienvenu T. An isoform of the severe encephalopathy-related CDKL5 gene, including a novel exon with extremely high sequence conservation, is specifically expressed in brain. 2011.
  42. Atipycal variants in Rett Syndrome: the role of CDKL5 and FOXG1. Russo S., Cogliari F.
    2012.
  43. Rusconi. 2008.
  44. Mutation in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Tao J., Van Esch H., Hagedorn-Greiwe M.,Hoffmann K., Moser B, Raynaud M. 2004, American journal of human genetics.
  45. Fehr S., Wilson M., Downs J., Williams S., Murgia A., Sartori S., Vecchi M., Ho G., Polli R., Psoni S., Bao X., de Klerk N., Leonard H., Christodoulou J. The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. 2013.
  46. FOXG1 Is responsible for the congenital variant of the Rett Syndrome. F.Ariani, G.Hayek, D.Rondinella, R.Artuso, M.A. Mencarelli, A. Spanhol-Rosseto, M.Pollazzon, S.Buoni, O.Spiga, S.Ricciardi, I.Meloni, I.Longo, F.Mari, V.Broccoli, M.Zappella, A.Ranieri. 2008, The American Journal of Human Genetics.
  47. FOXG1 Related Syndrome: From clinical to molecular genetics and pathogenic mechanism. L.C. Wong, S.Singh, H.P. Wang, C.J. Hsu, S.C. Hu, W.T. Lee. Taiwan : s.n., 2019, INternational journal of molecular science.
  48. Lion. 1961.
  49. Carrel L., Willard HF. Heterogeneous gene expression from the inactive X chromosome: an X-linked gene that escapes X inactivation in some human cell lines but is inactivated in others. 1999.
  50. Amos-Landgraf JM, Cottle A, Plenge RM, Friez M, Schwartz CE, Longshore J, Willard HF. X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. 2006.
  51. 5Abnormal X chromosomes in man: origin, behavior and effects. Therman E, Patau K. 1974.
  52. Functional disomies of the X chromosome influence the cell selection and hence the X inactivation pattern in females with balanced X-autosome translocations: a review of 122 cases. Schmidt M., Du Sart D. 1992.
  53. Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Plenge RM, Stevenson RA, Lubs HA, Schwartz CE, Willard HF. 2002.
  54. Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model. Muers MR, Sharpe JA, Garrick D, Sloane-Stanley J, Nolan PM, Hacker T, Wood WG, Higgs DR, Gibbons RJ. 2007.
  55. Preserved speech variant is allelic of classic Rett Syndrome. M.Zappella, C. De Bona, M.Bruttini, R.Cusano, G.Hayek, P.Loffredo, I. Meloni, I. Longo, F.Vitelli, A.Ranieri. Genova : s.n.,2000.
  56. M.Zappella. 1992.
  57. Should a syndrome be called by its correct name? The example of the preserved speech variant of Rett syndrome. Zappella M., Mari F., Renieri A. 2005.
  58. F.Hanefeld. 1985.
  59. Cyclin-Dependent Kinase-Like 5 (CDKL5) mutation screening in Rett syndrome and related disorders. Rose White, Gladys Ho, Swetlana Schmidt, Ingrid E. Scheffer,Alexandra Fischer,Simone C. Yendle. s.l. : Twin Research and Human Genetics, 2019. 
  60. The clinical features of early myoclonic encephalopathy caused by a CDKL5 mutation.Kanako Takeda un', B , ⇑ , Yusaku Miyamoto un' , B , Hisako Yamamoto un' , B , Atsushi Ishii c,. 2019.
  61. al., S.Rolando et. 1985.
  62. The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. Kortüm F, Das S, Flindt M, Morris-Rosendahl DJ, Stefanova I, Goldstein A, Horn D, Klopocki E, Kluger G, Martin P, Rauch A, Roumer A, Saitta S, Walsh LE, Wieczorek D, Uyanik G, Kutsche K, Dobyns WB. 2011.
  63. al., B.Hagberg et. 1994.
  64. B.Hagberg. 1986.
  65. al., S.Russo et. 2007.
  66. Rett Syndrome: Revised Diagnostic Criteria and Nomenclature. Neul, J.L, et al. 2010, National institute of health.
  67. Rett syndrome: criteria for inclusion and exclusion. Hagberg B, Goutières F, Hanefeld F, Rett A, Wilson J. 1985.
  68. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Hagberg B, Witt-Engerström I. 1986.
  69. Regression in Rett syndrome: Developmental pathways to its onset. Einspieler C., Marschik PB. 2019.
  70. Addressing developmental regression sequelae associated with disability of the development: A systematic review of behavioral intervention studies educational. je ff Sigafoos, Mark F. Reilly B , Katherine Ledbetter-Cho B , Nataly Lim B , Giulio E. Lancioni c. 2019.
  71. Rett Syndrome: Crossing the Threshold to Clinical Translation. Katz DM, Bird A, Coenraads M, Gray SJ, Menon D, Philpot BD, Tarquinio DC. 2016.
  72. Regression in Rett syndrome: developmental pathways at its onset. Marschik, Christa Einspieler Peter B. 2019.
  73. Rett syndrome and developmental regression. Eric E. Smeets, Gillian S. Townend, Leopold M.G. Curfs. 2019, Vol. Neuroscience and biobehavioral reviews.
  74. Neurologia pediatrica . Pavone L., Ruggeri M.,. Milano : s.n., 2006.
  75. Physiological analysis of motor pathways. Keele S. new york : Norton&Company, 1998, Cognitive Neuroscience- The biology of the mind.
  76. Action recognition in the premotor cortex. Gallese V., Fadiga L., Fogassi L., Rizzolatti G. 1996. 
  77. Movement, action, skill.Movement and child development. K.J., Conolly. 1975, Clinics in Developmental medicine.
  78. Tonic-neck-reflex and symmetro-tonic behavior; developmental and clinical aspects. Gesell A, Ames LB. 1946.
  79. An investigation into the development of early postural control. Green E.M, Mulcahy C.M, Pountney T.E. 1995.
  80. Prechtl's Methodd on the qualitative assesment of general movements in preterm, term and young infant. al., Einslpieler C. et. 2005.
  81. The qualitative assessment of general movements in preterm, term and y oung infants. C., Einspieler. 1997.
  82. lo sviluppo motorio del bambino. S., Zoia. roma : Carrocci, 2004.
  83. A. Antonietti, I.Castelli, R.A. Fabio, A. Marchetti. La sindrome di Rett.
  84. Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia. Marinelli, Currà, Trompetto, Capello, Serrati, Fattapposta, Pelosin , Phadke, Aymard, Puce, Molteni, Abbruzzese, Bandini. 2017.
  85. The Rett syndrome: gross motor disability and neural impairment in adults. Witt- Engerstrom I., Hagberg B. 1990.
  86. MOVEMENT DISORDERS IN RETT SYNDROME. Temudo, T. 2005.
  87. Scoliosis in Rett Syndrome: Progression, Comorbidities, and Predictors. John T. Killian, Jane B. Lane, Hye-Seung Lee, Steve A. Skinner,Walter E. Kaufmann, Daniel G. Glaze, Jeffrey L. Neul, Alan K. Percy. 2018.
  88. Rett syndrome: clinical and biological aspects. Hagberg B. London : s.n., 1993.
  89. Predictors of scoliosis in Rett syndrome . Ager S., Fyfe S., Christodoulou J., Jacoby P., Schmitt L., Leonard H,. 2006.
  90. Possible mechanism of osteopenia in Rett syndrome: bone histomorphometric studies.
    Budden S.S., Gunness M.E. 2003.
  91. Management for Rett syndrome: clinical and biological aspects. M., Lotan. 1993.
  92. MECP2 mutations and clinical correlations in Greek children with. Stavroula Psoni, Christalena Sofocleous, Joanne Traeger-Synodinos. 2012.
  93. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. Vishnu Anand Cuddapah, Rajesh B Pillai,Kiran V Shekar,Jane B Lane. 2014.
  94. The phenotype associated with a large deletion on MECP2. Bebbington, Downs J, Percy A, Pineda M, Zeev BB, Bahi-Buisson N, Leonard H. 2012. 
  95. Rett Syndrome and Associated Movement Disorders. Patricia M. FitzGerald, Joseph Jankovic, Alan K. Percy. 1990.
  96. Il comportamento Sindrome di Rett Questionnaire (RSBQ). Rebecca H. Monte, Tony Charma Richard P. Hastings, Sheena Reilly. 2002.
  97. Bruxism in Movement Disorders: A Comprehensive Review. Bruno Ella, Imad Ghorayeb, Pierre Burbaud. 2015.
  98. A Systematic Review of Animal-Assisted Therapy on Psychosocial Outcomes in People
    with Intellectual Disability. Sarah Maber-Aleksandrowicz, Cerian Avent, Angela Hassiotis. 2016.
  99. Attitudes to and Beliefs about Animal Assisted Therapy for Children with Disabilities.
    Esther Yap, Adam Scheinberg, Katrina Williams. 2016.
  100. G.F, Blue. The value of pets in children's life. Childhood education.
  101. Fine, Aubrey H. Handbook on Animal-Assisted Therapy: Theoretical Foundations and Guidelines for Practic. 2010.
  102. Effectiveness of animal-assisted therapy:A systematic review of randomizedcontrolled trials. Hiroharu Kamiokaa, Shinpei Okadab, Kiichiro Tsutanic,Hyuntae Parkd, Hiroyasu Okuizumie, Shuichi Handae,Takuya Oshiof, Sang-Jun Parkb, Jun Kitayuguchig,Takafumi Abeg, Takuya Hondah, Yoshiteru Mutohia. 2014.
  103. The effects of animal-assisted therapy on loneliness in an elderly population in long- term care facilities . Jul, Banks M.R. e W.A. Banks. 2002.
  104. Bocchicchio F., Falasconi A., Pesti M. e Nardone P. Un’esperienza di Terapia Assistita dagli Animali. 2002.
  105. Marine Mammals of the World. FAO Species Identification Guide. Jefferson T.A., Leatherwood S., Webber,M.A. 1993, Food and Agricultural Organization of the United Nations, Rome, Italy.
  106. he Sierra Club Handbook of Whales and Dolphins. Leatherwood S., Reeves R.R. 1983, T Sierra Club, San Francisco.
  107. Primo contributo alla conoscenza della specie Grampus griseus presso le coste sud orientali della Sardegna Natura. Arcangeli A., Marini L. 1997, Soc. it. Sci. Nat. Museo civ. Stor. Nat. Milano,, Vol. 90 (2), pp. 171-174.
  108. Diet of the bottlenose dolphin (Tursiops truncatus) in the western Mediterranean Sea. Blanco C., Salomón O., Raga J.A. 2001, Journal of the Marine Biological Association of the UK, Vol. 81, pp. 1053-1058. 
  109. Where to catch a fish? The influence of foraging tactics on the ecology of bottlenose dolphin (Tursiops truncatus) in Florida Bay. Torres L.G., Read A.J. 2009, Marine Mammal Science, Vol. 25 (4), pp. 797–815.
  110. The social organization and behavior of dolphins (Tursiops truncatus) and baboons (Papio ursinus): some comparisons and assessments. Tayler C.K., Saayman G.S. 1972, Ann. Cape Prov. Mus. Nat. Hist. (South Africa), pp. 11-49.
  111. M., Lotan. Rett syndrome. A review with Emphasis on clinical characteristics and intervention. 2006, Vol. 6, pp. 1517-1541.
  112. redemacher. 2011.
  113. Fichou. 2011.
  114. White. 2010.
  115. Mari. 2005.
  116. Kameshita. 2008.
  117. al., Bahi-Buisson et. 2010.
  118. al., Le Guen et. 2011.
  119. NTING1 Mutations are a rare cause of rett syndrome . Archer H.L, Evans J., Millar D.S., Thampson P.W,Kerr A., Leonard H., Christodolou J., Ravine D., Lazarou L., Verity C., Whatley S.D, Pilz D.T, Sampson J.R., Clark A.J. 2006.
  120. Motor Abilities are related to specific genotypes in Rett Syndrome. Fabio R.A, Caprì T., Lotan M.,Towey G.E., Martino G. 2018.
  121. Mencarelli M.A, Spanhol-Rosseto A., Artuso R., Rondinella D., De Filippis R., Bahi-Buisson N., Nectoux J., Rubinsztajn R., Bienvenu T., Moncla A., Chabrol B., Villard L., Krumina Z., Armstrong J., Roche A., Pineda M., Gak E., Mari F., Ariani F., Renieri A. Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. 2010.